Keywords: Takeda, Daiichi Sankyo, First-quarter 2012 financial results

First-quarter FY 2012 net profit at Takeda jumps 18%, while that at Daiichi Sankyo slumps 23.5%

Article | 02 August 2011

Print This

There were mixed financial reports from Japanese drugmakers, with the country’s biggest, Takeda (TYO: 4502), putting in a strong ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in